Bullboard - Stock Discussion Forum Sonnet Biotherapeutics Holdings Inc SONN

Consumer Cyclical Biotechnology

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company with a proprietary platform for biologic medicines of single-or bifunctional action. Its technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. It designed the... see more

Add To Watchlist

NDAQ:SONN - Post Discussion

Sonnet Biotherapeutics Holdings Inc > Sonnet BioTherapeutics to Participate in the Virtual Investo

View:

Post by whytestocks on Sep 04, 2024 1:00pm

Sonnet BioTherapeutics to Participate in the Virtual Investo

Breaking News: $SONN Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell SeriesPRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that it will participate in the Virtual Investo...SONN - Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series

162